PRAXBIND 2.5 g/50 ml, solution for injection/for infusion 2 bottles of 50 ml
Active ingredients: Idarucizumab
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection or infusion2 bottles of 50 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PRAXBIND 2,5 g/50 ml, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 2 flacon(s) en verre de 50 ml
- Marketing authorisation holder
- BOEHRINGER INGELHEIM INTERNATIONAL
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Feb 2016
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63555182CIP75501369CIP133400955013693Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IDARUCIZUMABsolution | 50 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.